![Biomedicines | Free Full-Text | Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches Biomedicines | Free Full-Text | Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches](https://pub.mdpi-res.com/biomedicines/biomedicines-10-02236/article_deploy/html/images/biomedicines-10-02236-ag.png?1663296353)
Biomedicines | Free Full-Text | Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
![Amazon.com: La dieta antinfiammatoria per l'intestino: Prefazione e cinque ricette di Marco Bianchi (Dieta e benessere) (Italian Edition): 9788844052133: Danese, Silvio: ספרים Amazon.com: La dieta antinfiammatoria per l'intestino: Prefazione e cinque ricette di Marco Bianchi (Dieta e benessere) (Italian Edition): 9788844052133: Danese, Silvio: ספרים](https://m.media-amazon.com/images/I/61IUvkMIySL._AC_UF350,350_QL80_.jpg)
Amazon.com: La dieta antinfiammatoria per l'intestino: Prefazione e cinque ricette di Marco Bianchi (Dieta e benessere) (Italian Edition): 9788844052133: Danese, Silvio: ספרים
![PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment](https://i1.rgstatic.net/publication/283498430_Oral_Probiotic_VSL3_Prevents_Autoimmune_Diabetes_by_Modulating_Microbiota_and_Promoting_Indoleamine_23-Dioxygenase-Enriched_Tolerogenic_Intestinal_Environment/links/61851aaeeef53e51e130fdf8/largepreview.png)
PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome | PLOS ONE
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation | PLOS ONE
![Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain | Journal of Neuroscience Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/35/30/10821/F2.large.jpg)
Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain | Journal of Neuroscience
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation | PLOS ONE
![PDF) Probiotic VSL#3-induced TGF-β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa | Gabriella Felice - Academia.edu PDF) Probiotic VSL#3-induced TGF-β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa | Gabriella Felice - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42615019/mini_magick20190217-31976-1heluzb.png?1550427401)
PDF) Probiotic VSL#3-induced TGF-β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa | Gabriella Felice - Academia.edu
![PDF) Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219. Review. PubMed PMID: 26900286; PubMed PDF) Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219. Review. PubMed PMID: 26900286; PubMed](https://i1.rgstatic.net/publication/296332319_Distrutti_E_Monaldi_L_Ricci_P_Fiorucci_S_Gut_microbiota_role_in_irritable_bowel_syndrome_New_therapeutic_strategies_World_J_Gastroenterol_2016_Feb_212272219-41_doi_103748wjgv22i72219_Review_PubMed_PMI/links/5af18251aca272bf4255bce0/largepreview.png)
PDF) Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219. Review. PubMed PMID: 26900286; PubMed
![PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment](https://www.researchgate.net/profile/Chiara-Sorini/publication/283498430/figure/fig5/AS:1086751141564418@1636113071143/VSL3-probiotic-administration-protects-against-T1D-by-changing-the-intestinal-microbiota_Q320.jpg)
PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
![PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment](https://www.researchgate.net/profile/Chiara-Sorini/publication/283498430/figure/fig3/AS:1086751141560327@1636113071056/All-trans-retinoic-acid-RA-does-not-enhance-the-protective-effect-of-the-VSL3_Q320.jpg)
PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
![The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | American Journal of Physiology-Gastrointestinal and Liver Physiology The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00265.2006/asset/images/medium/zh30010746300002.jpeg)
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
![PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment](https://www.researchgate.net/profile/Chiara-Sorini/publication/283498430/figure/fig1/AS:1086751141572614@1636113071014/All-trans-retinoic-acid-RA-does-not-enhance-the-protective-effect-of-the-VSL3_Q320.jpg)
PDF) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
![Pharmaceuticals | Free Full-Text | The Probiotic VSL#3® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Pharmaceuticals | Free Full-Text | The Probiotic VSL#3® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01063/article_deploy/html/images/pharmaceuticals-14-01063-g003.png)